Delivery Order SPE2DB24D2212-SPE2DB24FHMXH

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,559.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,069.45 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA), a defense agency. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This federal contract award, valued at $4,741.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564653296 ! ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $2,105.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4564682483 - ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of various medical products and prescription drugs. The contract, valued at up to $3,702.40, is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $26,250.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and is a Firm Fixed Price Delivery Order with a completion date of June 13, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award, valued at $1,580.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of 4565096503 ! ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML" to the Defense Logistics Agency (DLA). The contract, valued at $1,053.76, is a firm-fixed price delivery order with a completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $1,053.76. The contract is for the supply of the pharmaceutical product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. This award is not designated as a Set-Aside contract. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order valued at $4,588.43 to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the supply of 4565406398 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of August 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, providing a wide range of essential medications and supplies...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB24FHMXH
    Delivery Order

This federal contract award, valued at $2,614.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of June 26, 2024 and is structured as a Delivery Order under a Firm Fixed Price pricing arrangement.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award was not designated as a set-aside. Amerisourcebergen's expertise in pharmaceutical distribution and its position as a major supplier to government agencies, particularly the Department of Defense and Veterans Affairs healthcare systems, have allowed the company to secure numerous federal contract awards.

Generated 9/24/24, 9:28 AM